Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

Metropolis Healthcare announces H1FY20 results

Posted On: 2019-11-12 10:21:43

Metropolis Healthcare Ltd (NSE: METROPOLIS | BSE: 542650) - a leading diagnostic service provider - announced its un-audited consolidated financial results today for the quarter ended September 30, 2019.

Key performance highlights (consolidated): Q2FY20 vs. Q2FY19

- Consolidated revenue growth of 15.6% @ 223 Crore backed by robust volume growth
- Robust operating performance
- Growth in total number of patients: 15.7% | Growth in number of tests performed: 20.1%
- Accounting EBIDTA @ INR 63 Crore, 28.0% on revenue (18.8% growth)
- Reported PAT @ INR 43 crore, 19.3% on revenue (43.7% growth)

Key performance highlights (consolidated): H1FY20 vs. H1FY19

- Consolidated revenue grew by 15.6% to Rs. 427 Crs as compared to 369 Crs in H1FY19 driven by volume growth through organic expansion.

- EBIDTA margins for H1FY20 were 27.58% as compared to 26.30% and EBIDTA for the half year stood at Rs. 118 Crs as compared to 97 Crs in H1FY19, a growth of 21.3%

- B2C sales increased to 44.4% in H1FY20 as compared to 43.6% in H1FY19, a growth of 80bps

- Total patient visit has increased from 4.23 Mn in H1FY19 to 4.92 Mn in H1FY20 registering a growth of 16.3% Y-o-Y

- Number of tests performed has increased to 9.51 Mn in H1FY20 from 7.91 Mn in H1FY19 registering a growth of 20.3% Y-o-Y

"I am happy to present our quarterly and half yearly results. We have been witnessing a consistent and stable growth in number of tests and patient visits. This is evident from the increase in revenue contribution from our retail business which reinforces patient trust and preference for Metropolis. In our endeavor to offer tests that are critical for correct diagnosis, we have added 14 new specialized tests in the area of oncology, genetics and transplant pathology. We are also pleased to welcome aboard Ms. Ishita Medhekar in the role of CHRO and Mr Rakesh Agarwal as CFO. We will continue to be driven in our pursuit to deliver excellence in pathology while delivering value for all our stakeholders", said Ms Ameera Shah - Managing Director.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

Glenmark's Baddi manufacturing facility receives Certificate of Compliance from European regulator, SUKL, Czech Republic

RIL arm enters into agreement with Brookfield for investment of Rs. 25215 crore

Sun Pharma gets 8 observations from US FDA for Halol Facility

Infibeam Avenues Ltd appoints Mr. R Srikanth as President - Finance & Investor Relations

Aster RV Hospital Organizes Inclusive Dance and Music Festival for the Differently Abled

Titan Company Launches 'Fastrack Perfumes', announces Ananya Panday as the New Face

Vedavaag Systems Limited and enter into MoU

Asian Oilfield Services Ltd secures Rs 640-crore seismic data acquisition work

Jubilant Industries subsidiary to recommence operations from May 15, 2020

Adani Transmission Limited receives LoI for Transmission Project in the State of Maharashtra

R Systems International Limited Board approves interim dividend of Rs. 1.50 for 2019

Prabhat Technologies launches parenteral control mobile application

Karnataka Bank launches KBL Xpress Car Loan

Aditya Vision Ltd opens 41st showroom

Hester Biosciences Ltd board to consider fund raising through issue of equity shares

Ashiana Housing Ltd announces conversion of EoI into booking for Phase 1 of 'Ashiana Aditya'

CARE A1+ rating assinged to Shree Cement's Commercial Paper

ABANS ENTERPRISES LTD announces resignation of CFO

RIL arm acquires 51.78% stake in Asteria

REC Ltd transfers stake in Rampur Sambhal Transco Limited to Powergrid

Wipro Promax Analytics Solutions recognised by Promotion Optimization Institute

Zensar participates in the 'Women in the Workplace 2019' report by McKinsey and LeanIn.Org

AU Bank announces the completion of Temasek's investment for 4.8% stake

BGR Energy Systems bags order from TANGEDCO

Acuite Ratings reaffirms A3+ rating for Dynacons' short term instruments

Premier Explosives Ltd receives license from Telangana Government

Kansai Nerolac dedicates an exclusive installation to Visakhapatnam under its 'Breathing City' initiative

TCS wins CII Industrial IP Award for Best Patents Portfolio

Metropolis Healthcare wins Patient Experience Team of the Year award

Mastek Limited sells its partial stake in Majesco to drive growth strategy

UFO Moviez Unveils New Brand Identity to Reinforce its Cinema Advertising Offering

Infosys Ltd updates on class action lawsuit

Magma Fincorp raises INR 350 Cr. from FMO - the Dutch Development Bank

Majesco Ltd to increase stake in Majesco USA to 74.6%

Smt. Usha Sangwan ceased to be nominee director of AXIS Bank Ltd

Vipin Sondhi appointed as MD & CEO of Ashok Leyland

Let us not forget our Fundamental duties in the clamour for Fundamental Rights

Biocon & Equillium Expand Exclusive Licensing Agreement for Itolizumab to Include Australia and New Zealand

IDEGO and EdgeVerve Join Hands to Drive RPA Adoption Across Latin America

Brickwork reaffirms ratings of SRG Housing Finance Limited

Sambhaav Media Ltd commences FM Radio Station at Bhaderwah (J&K) (94.3 MHz)

Embassy Group's HR Practices and Workplace Culture earns Top Rank in the Industry

Persistent Systems announces new leadership for unified Salesforce practice in Europe

Navin Fluorine International Ltd plans capex at Dahej, Gujarat

Datamatics to Strategically Divest its Stake in Cignex Datamatics Inc.

Aster DM Healthcare Ltd increases stake in Prerana Hospital Ltd to 86.99%

Kesar Enterprises Ltd accepts OTS with Allahabad Bank, UCO Bank

South African Depository Consolidates All Operations on to TCS BaNCS™ for Market Infrastructure

One of the leading Global Business Process Outsourcing Company Goes Live on Ramco

Wipro wins the '2019 SUSE Global System Integrator Partner of the Year' award

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019